IBD: Crohn's Disease

Biosimilars for IBD: Making the Transition Webinar

On May 28th, Dr. McCurdy answered the following questions in a very informative webinar presentation on Biosimilars:

  • What’s the difference between a reference biologic drug and a biosimilar?
  • Biosimilars: What’s Health Canada saying?
  • What is the clinical evidence to date?
  • How do doctors go about transitioning their patients from a reference biologic drug to a biosimilar?

Watch this webinar now!

Biosimilars for IBD: Making the Transition Webinar

[embed]https://www.youtube.com/watch?v=XG3F9LyMS5g&feature=youtu.be[/embed] On May 28th, Dr. McCurdy answered the following questions in a very informative webinar presentation on Biosimilars:
  • What’s the difference between a reference biologic drug and a biosimilar?
  • Biosimilars: What’s Health Canada saying?
  • What is the clinical evidence to date?
  • How do doctors go about transitioning their patients from a reference biologic drug to a biosimilar?
Watch this webinar now!
Close

Where are you experiencing discomfort?

Click on the buttons on the body to the left or click from the list below where you are experiencing discomfort.